Literature DB >> 8979058

Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer.

B S Sheu1, H B Yang, I J Su, S C Shiesh, C H Chi, X Z Lin.   

Abstract

BACKGROUND: We studied whether different initial bacterial densities of Helicobacter pylori would alter the eradication rate of H. pylori by triple therapy (amoxicillin 500 mg t.i.d. and metronidazole 500 mg t.i.d. for 14 days; bismuth subcitrate 120 mg t.i.d. for 28 days) in patients with duodenal ulcer bleeding.
METHOD: One hundred thirty-six cases with duodenal ulcer bleeding and H. pylori infection (proved by rapid urease test and histology during emergency endoscopy) were studied. One hundred twenty-seven of these patients completed a course of triple therapy. In each case, anti-H. pylori IgG titer, gastric biopsies for H. pylori density (score 1 to 5), and evaluation of severity of gastritis were collected at the first endoscopy and 1 month after completion of the triple therapy.
RESULTS: The ulcer healing rate was 84.3% (107 of 127) at the time of the second evaluation. The eradication rate of H. pylori was 76.4% (97 or 127). Eradication for H. pylori failed in 30 cases. In these eradication failure cases, initial serologic titer and density of H. pylori were higher than those of eradication success cases. The eradication rate of H. pylori decreased as the initial density of H. pylori increased (density of H. pylori: 1, 88.3%; 2, 83.8%; 3, 74.2%; 4, 68%; 5, 50%). At the second evaluation, the serologic titer was lower and continued to decline in eradication success cases whose mean residual titer ratio (100% x follow-up titer/initial titer) was lower than that of eradication failure cases (57.1% +/- 14.6% vs 107.1% +/- 24.1%, p < 0.001). The mean residual titer ratio also disclosed an upward trend as the density of H. pylori increased (density of H. pylori 1 to 5: 57.5%, 66.6%, 73.5%, 75.3%, 81.8%, respectively).
CONCLUSIONS: We suggest routine gastric biopsy to detect both the presence of H. pylori and its density inasmuch as quantitative results may predict the usefulness of triple therapy. The higher the H. pylori density, the less effective triple therapy will be at successful eradication of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8979058     DOI: 10.1016/s0016-5107(96)70052-4

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  16 in total

1.  Gender-associated differences in urea breath test for Helicobacter pylori infection referrals and results among dyspeptic patients.

Authors:  Menachem Moshkowitz; Noya Horowitz; Anat Beit-Or; Zamir Halpern; Erwin Santo
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

2.  Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis.

Authors:  H Miwa; H Misawa; T Yamada; A Nagahara; K Ohtaka; N Sato
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Quantifying gastric Helicobacter pylori infection: a comparison of quantitative culture, urease breath testing, and histology.

Authors:  Sanjeev Tummala; Sunil G Sheth; Jeffrey D Goldsmith; Atoussa Goldar-Najafi; Christopher K Murphy; Marcia S Osburne; Steven Mullin; Debra Buxton; David A Wagner; Ciarán P Kelly
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

Review 4.  A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.

Authors:  U Peitz; A Hackelsberger; P Malfertheiner
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 5.  Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

6.  Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study.

Authors:  Tolga Erim; Marcia R Cruz-Correa; Samuel Szomstein; Evelio Velis; Raul Rosenthal
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

7.  Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.

Authors:  Yung-Chih Lai; Teh-Hong Wang; Shih-Hung Huang; Sien-Sing Yang; Chi-Hwa Wu; Tzen-Kwan Chen; Chia-Long Lee
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers.

Authors:  Yung-Chih Lai; Jyh-Chin Yang; Shih-Hung Huang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

9.  13C-urea breath test values and Helicobacter pylori eradication.

Authors:  Angelo Zullo; Federico Perna; Chiara Ricci; Cesare Hassan; Andrea Tampieri; Vincenzo De Francesco; Sergio Morini; Dino Vaira
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

10.  Severe gastritis decreases success rate of Helicobacter pylori eradication.

Authors:  Ismail Hakki Kalkan; Ferdane Sapmaz; Sefa Güliter; Pınar Atasoy
Journal:  Wien Klin Wochenschr       Date:  2015-12-04       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.